With the continuing cuts to US Food and Drug Administration (FDA) staffing, the pharmaceutical and biotechnology industries are communicating increasing concern about potential product development impacts. While these cuts...more
Artificial intelligence (AI) is reshaping modern society, enabling the automation and modification of routine human activities and, consequently, enhancing efficiency and productivity. Like any technological development, AI...more
While artificial intelligence has not quite yet achieved singularity, the last fortnight brought about a substantial update to the AI regulatory landscape. As of February 2, Chapters I and II of the EU AI Act have entered...more
The Court of Justice of the European Union (CJEU), the EU’s highest court, recently announced its significant Lindenapotheke decision, permitting companies to use the General Data Protection Regulation in business-to-business...more
The European Union published on July 12, 2024 the final text of its Artificial Intelligence (AI) Act, in force on August 1, 2024, which will implement material cybersecurity and incident reporting requirements, among other...more
The world is witnessing a flurry of activity surrounding issues of data protection, cybersecurity, artificial intelligence (AI), and consumer privacy. According to the National Conference of State Legislators, some 40 US...more